arrow
A

Arjen M. Rijken

st. antonius hospital utrecht
H指数:23
被引数:1,982

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trial

初始不可切除的结直肠癌肝转移:一阶段手术与两阶段手术的比较——CAIRO5试验的事后分析

2025-12-010
OAAI
Selection for local treatment and Outcomes of surgical resection in patients with Synchronous Colorectal Liver Metastases: A Nationwide Population-Based Study.

同步结直肠癌肝转移患者的局部治疗选择与手术切除结局:一项全国性基于人群的研究。

2025-08-280
OAAI
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases:An ancillary study of the phase 3 CAIRO5 trial

总肿瘤体积可预测结直肠癌肝转移患者总生存期及诱导化疗反应:CAIRO5三期试验的辅助研究

2025-08-210
PREAI
Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment
EJSO
IF2.9
2025-06-010
PRE
Risk factors and outcomes of conversions in robotic and laparoscopic liver resections: A nationwide analysis
SURGERY
IF2.7
2025-02-010
PRE
Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation
2024-08-011
PRE
Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases

用于结直肠癌肝转移患者肿瘤自动分割和总肿瘤体积评估的深度学习模型

2023-12-015
OAAI
First-line systemic treatment in patients with initially unresectable colorectal cancer liver metastases (CRLM): Overall survival of the phase III CAIRO5 study of the Dutch Colorectal Cancer Group
2023-10-015
OAAI
Survival of patients with colorectal liver metastases treated with and without preoperative chemotherapy: Nationwide propensity score-matched study

术前化疗和未化疗的结直肠癌肝转移患者的生存率: 全国倾向评分匹配研究

EJSO
IF2.9
2023-09-016
OAAI
ASO Visual Abstract: Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases-Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
2023-05-300
PRE
Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
2023-04-2810
OAAI
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial
2023-04-018
OAAI
FOLFOX/FOLFIRI plus either bevacizumab or panitumumab in patients with initially unresectable colorectal liver metastases (CRLM) and left-sided and RAS/BRAFV600E wild-type tumour: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group
2022-09-015
OA
Interobserver Variability in CT-based Morphologic Tumor Response Assessment of Colorectal Liver Metastases
2022-05-016
OA
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres
2021-07-0117
OA
Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases
EJSO
IF2.9
2021-03-0118
OAAI